Fig. 4From: Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarkerDiagnostic performance of the top five DEPs with AUC > 0.80 and serum AFP. a Receiver operating characteristic (ROC) curve shows the predictive power of the top 5 DEPs with AUC > 0.80. b ROC curve of serum AFP for HCC patients versus healthy subjects. c ROC curve of combination AFP and ANGPTL6. HCC, hepatocellular carcinoma, DEPs, differentially expressed proteinsBack to article page